Becton, Dickinson and Co

Traded on the St. Petersburg Stock Exchange
Becton, Dickinson and Company, commonly known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies. BD employs nearly 70,000 people in more than 50 countries throughout the world. Today, BD is divided into three segments: BD Medical, BD Life Sciences and BD Interventional.
Becton, Dickinson and Co stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Becton, Dickinson and Co balance sheet

Report period2019 2020 2021 20222023 Q1 24
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Becton, Dickinson and Co cash flows

Report period2019 2020 2021 20222023 Q1 24 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Becton, Dickinson and Co multipliers

Report period2019 2020 2021 20222023 Q1 24 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Becton, Dickinson and Co profitability

Report period2019 2020 2021 20222023 Q1 24 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Becton, Dickinson and Co assets
Becton, Dickinson and Co cash flows
Becton, Dickinson and Co dividends
1.51%

Becton, Dickinson and Co shares

TickerNameTypeNominal valueISINPrice
BDX:USBecton Dickinson and CompanyCommon share-US0758871091$246.2
Becton, Dickinson and Co news
05.05.2022
Becton, Dickinson and Co.'s GAAP net income for 6 months of fiscal 2022 was $1.131 billion, down 13.1% from $1.302 billion in the prior year. Revenue declined 2.1% to $10.006 billion from $10.223 billion a year earlier.
Source: {source} pictogram investors.bd.com
Pictogram next
27.04.2022
The Becton, Dickinson and Co Board of Directors announced a quarterly dividend of $0.87 per share. The last day to buy securities to receive the dividend is June 7, 2022. The annual dividend yield may reach 1.31%.
Source: {source} pictogram investors.bd.com
Pictogram next
01.04.2022
Becton, Dickinson & Co. has completed the spin-off of its diabetes business into a separate public company, Embecta. Becton, Dickinson shareholders received one Embecta share for every five of their securities. Effective today, Embecta shares began trading on the NASDAQ exchange under the ticker EMBC.
Source: {source} pictogram investors.bd.com
Pictogram next
03.02.2022
Becton, Dickinson and Co's GAAP net income for 3 months of fiscal year 2022 was $0.677 billion, down 32.5% from $1.003 billion in the prior year. Revenue declined 6% to $4.995 billion from $5.315 billion a year earlier.
Source: {source} pictogram investors.bd.com
Pictogram next
All Becton, Dickinson and Co news
General information
Company nameBecton, Dickinson and Co
Tags#dividend aristocrats, #s&p500 index
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Supplies
Business addressONE BECTON DR FRANKLIN LAKES NJ 07417-1880 2018476800
Mailing addressONE BECTON DR FRANKLIN LAKE NJ 07417
Websiteinvestors.bd.com
Information disclosurewww.sec.gov